Clinical Trial Update: QIAstat-Dx® Meningitis/Encephalitis Panel Performance Evaluation Study 001

View source ↗

Summary

Completed performance evaluation of the QIAstat-Dx Meningitis/Encephalitis Panel in detecting pathogens causing meningitis and encephalitis (Study 001).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Encephalitis
• Meningitis

Drugs mentioned

• QIAstat-Dx Meningitis/Encephalitis Panel

Snippet

Sponsor: QIAGEN Gaithersburg, Inc | Conditions: Meningitis/Encephalitis | Status: COMPLETED